Researchers at the Indian Institute of Science (IISc) have developed a novel artificial nanozyme made from vanadium pentoxide that mimics natural antioxidant enzymes to regulate blood clotting. This innovation targets abnormal platelet activation caused by oxidative stress, a key factor in conditions like pulmonary thromboembolism and ischemic stroke. By safely controlling Reactive Oxygen Species (ROS), the nanozyme offers a promising alternative to conventional antiplatelet therapies.
My exclusive interview with the lead researcher-scientist of the study Prof. G Mugesh, at the Department of Inorganic and Physical Chemistry, IISc.
Leave a comment